Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Eli Lilly
Stated: Lilly’s[2] October 15, 2026 announcement confirms results on October 29 and says “The conference call will begin at 10 a.m. Eastern time.” The issuer’s event page independently lists October 29, 2026 at 10:00 AM EDT (14:00 UTC).
Eli Lilly is expected to report third-quarter 2026 results on 29 October, with its usual 10 a.m. ET conference call. It goes in guiding to $85-87 billion of 2026 revenue after second-quarter revenue jumped 48% to $23.0 billion on Mounjaro and Zepbound.